Neuromuscular Disorders News

Feb 20, 2017
Mercury in fish, seafood may be linked to higher risk of amyotrophic lateral sclerosis
Eating fish and seafood with higher levels of mercury may be linked to a higher risk of amyotrophic lateral sclerosis (ALS), according to a preliminary study released today that will be presented at the American Academy of Neurology's 69th Annual Meeting. However, fish and seafood consumption as a regular part of the diet was not associated with ALS.
Feb 14, 2017
Children of patients with C9orf72 mutations at greater risk of frontotemporal dementia / ALS
Researchers have demonstrated that if an affected parent passes on the C9orf72 mutation, the children will be affected at a younger age than the parent. There are no indications that the disease progresses more quickly. These results are published today in JAMA Neurology.
Jan 26, 2017
Gene therapy for Pompe disease effective in mice, poised for human trials
After decades investigating Pompe disease, Duke Health researchers have developed a gene therapy they hope could enhance or even replace the only FDA-approved treatment currently available to patients. The therapy uses a modified virus to deliver a gene to the liver where it produces GAA.
Jan 09, 2017
Experiments in mice may help boost newly FDA-approved therapy for spinal muscular atrophy
A new biological target for treating spinal muscular atrophy has been identified. An article in Neuron reports an experimental medicine aimed at this target works as a "booster" in conjunction with a drug called Nusinersen that was recently FDA-approved to improve symptoms of the disorder in mice.
Nov 08, 2016
Collapse of mitochondria-associated membrane in ALS
A research team found that collapse of the mitochondria-associated membrane is a common pathological hallmark to 2 distinct inherited forms of amyotrophic lateral sclerosis (ALS): SOD1- and SIGMAR1- linked ALS. The research findings were reported in EMBO Molecular Medicine.
Oct 19, 2016
A vitamin could help treat Duchenne muscular dystrophy
Researchers at the EPFL in Switzerland have discovered that large doses of the vitamin nicotinamide riboside were remarkably effective in countering the progress of Duchenne muscular dystrophy in animals. Their work has been published in Science Translational Medicine.
Sep 22, 2016
Stabilizing SOD1 protein can help prevent formation of toxic oligomers
In a new study published in the journal Structure, researchers report that stabilizing SOD1 is protective for motor neuron-like cells. They also have found a way to mutate disease-associated SOD1 in order to stabilize it, which offers exciting new leads for drug development.
Sep 19, 2016
Glutamate plays previously unknown role in neuromuscular development
For decades, scientists thought acetylcholine was the only neurotransmitter responsible for controlling how muscles and nerves are wired together during development. Turns out, they were wrong. Glutamate is also necessary. Researchers reported their findings with mice in the Journal of Neuroscience.
Aug 11, 2016
Thymectomy provides broad benefit to myasthenia gravis patients without a chest tumor
A study published in the New England Journal of Medicine August 11 is the first-ever randomized trial of thymectomy. It reports that surgical removal of the thymus gland from patients with myasthenia gravis provides significant benefit in patients who both have a thymoma and those without.
Aug 04, 2016
New microfluidic chip replicates muscle-nerve connection
MIT engineers have developed a microfluidic device that replicates the neuromuscular junction. The team's results, published online in Science Advances, may help scientists understand and identify drugs to treat amyotrophic lateral sclerosis as well as other neuromuscular-related conditions.
Next ▶